These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11493093)

  • 1. Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection.
    Gilbert J; Drehs MM; Weinberg JM
    Arch Dermatol; 2001 Aug; 137(8):1015-7. PubMed ID: 11493093
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical imiquimod treatment of aciclovir-resistant herpes simplex disease: case series and literature review.
    Perkins N; Nisbet M; Thomas M
    Sex Transm Infect; 2011 Jun; 87(4):292-5. PubMed ID: 21406577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.
    Tandon S; Singh J; Sinha S; Sharma DP
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28261899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of oral acyclovir and imiquimod for the treatment of hypertrophic genital herpes simplex in HIV positive patients: report of two cases.
    Barbosa Ldo N; Souto R; Furtado AL; Gripp AC; Daxbacher E
    An Bras Dermatol; 2011; 86(5):1043-5. PubMed ID: 22147057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of hypertrophic herpes simplex genitalis in HIV-infected patient with topical imiquimod.
    Deza G; Martin-Ezquerra G; Curto-Barredo L; Villar García J; Pujol RM
    J Dermatol; 2015 Dec; 42(12):1176-8. PubMed ID: 26074211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic genital ulceration due to herpes simplex infection treated successfully with imiquimod.
    Bangsgaard N; Skov L
    Acta Derm Venereol; 2008; 88(2):202-3. PubMed ID: 18311468
    [No Abstract]   [Full Text] [Related]  

  • 7. Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes.
    Brummitt CF
    Clin Infect Dis; 2006 Feb; 42(4):575. PubMed ID: 16421805
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study.
    Leeyaphan C; Surawan TM; Chirachanakul P; Prasertworonun N; Punyaratabandhu P; Omcharoen V; Jiamton S
    Int J Infect Dis; 2015 Apr; 33():165-70. PubMed ID: 25660091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod.
    McKendry A; Narayana S; Browne R
    Int J STD AIDS; 2015 May; 26(6):441-3. PubMed ID: 24912536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study.
    Schacker TW; Conant M; Thoming C; Stanczak T; Wang Z; Smith M
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3243-8. PubMed ID: 12234851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic perianal herpes successfully treated with imiquimod.
    Lestre SI; João A; Carvalho C; Serrão VV
    An Bras Dermatol; 2011; 86(6):1185-8. PubMed ID: 22281910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical imiquimod for recurrent acyclovir-resistant HSV infection.
    Martinez V; Molina JM; Scieux C; Ribaud P; Morfin F
    Am J Med; 2006 May; 119(5):e9-11. PubMed ID: 16651045
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment to: topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions Al-Waili NS Med Sci Monit, 2004; 10(8): MT94-MT98.
    Carilli S
    Med Sci Monit; 2005 Dec; 11(12):LE24. PubMed ID: 16319801
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir.
    Safrin S; Schacker T; Delehanty J; Hill E; Corey L
    Antimicrob Agents Chemother; 1993 May; 37(5):975-9. PubMed ID: 8390815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for herpes simplex virus infections.
    Erlich KS; Mills J
    West J Med; 1985 Nov; 143(5):648-55. PubMed ID: 3909643
    [No Abstract]   [Full Text] [Related]  

  • 16. Vegetative chronic genital herpes with satisfactory response to imiquimod.
    Siqueira SM; Gonçalves BB; Loss JB; Estrella RR
    An Bras Dermatol; 2019; 94(2):221-223. PubMed ID: 31090830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod.
    Abbo L; Vincek V; Dickinson G; Shrestha N; Doblecki S; Haslett PA
    Clin Infect Dis; 2007 Feb; 44(3):e25-7. PubMed ID: 17205432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical Presentation of Herpes Simplex Virus Type 2 Infection Refractory to Treatment With Aciclovir in 2 Hematologic Patients.
    Nieto Rodríguez D; Sendagorta Cudós E; Rueda Carnero JM; Herranz Pinto P
    Actas Dermosifiliogr (Engl Ed); 2019 Jun; 110(5):393-397. PubMed ID: 29203034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of recalcitrant herpes simplex virus with topical imiquimod.
    Hirokawa D; Woldow A; Lee SN; Samie F
    Cutis; 2011 Dec; 88(6):276-7. PubMed ID: 22372165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local treatments using antiviral and non-antiviral drugs for herpes facialis and genitalis (excluding pregnant females and neonates at risk)].
    Chosidow O; Lebrun-Vignes B
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):635-45. PubMed ID: 12122334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.